• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombospondin-1 in Chronic Kidney Disease Driven Cardiac Dysfunction: More Than Just a Biomarker?

作者信息

Kiss Attila

机构信息

Ludwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.

出版信息

JACC Basic Transl Sci. 2024 May 27;9(5):628-630. doi: 10.1016/j.jacbts.2024.03.008. eCollection 2024 May.

DOI:10.1016/j.jacbts.2024.03.008
PMID:38984041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11228109/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11228109/253ef159c170/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11228109/253ef159c170/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c019/11228109/253ef159c170/ga1.jpg

相似文献

1
Thrombospondin-1 in Chronic Kidney Disease Driven Cardiac Dysfunction: More Than Just a Biomarker?慢性肾脏病所致心脏功能障碍中的血小板反应蛋白-1：仅仅是一种生物标志物吗？
JACC Basic Transl Sci. 2024 May 27;9(5):628-630. doi: 10.1016/j.jacbts.2024.03.008. eCollection 2024 May.
2
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.替米沙坦可改善射血分数保留型心力肾衰所致的心肌纤维化和舒张功能障碍。
Exp Biol Med (Maywood). 2021 Dec;246(23):2511-2521. doi: 10.1177/15353702211035058. Epub 2021 Aug 3.
3
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.心肾综合征中的生物标志物及对新型治疗方法的潜在见解
Front Cardiovasc Med. 2022 May 20;9:868658. doi: 10.3389/fcvm.2022.868658. eCollection 2022.
4
Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease.血小板反应蛋白-1驱动慢性肾病中的心脏重塑。
JACC Basic Transl Sci. 2024 Mar 27;9(5):607-627. doi: 10.1016/j.jacbts.2024.01.010. eCollection 2024 May.
5
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.异体细胞联合治疗改善射血分数保留的慢性肾脏病引起的心力衰竭。
Stem Cells Transl Med. 2022 Mar 3;11(1):59-72. doi: 10.1093/stcltm/szab004.
6
Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.射血分数保留的心力衰竭患者肝脏硬度与舒张功能、左心室肥厚及右心功能的相关性
Front Cardiovasc Med. 2021 Nov 25;8:748173. doi: 10.3389/fcvm.2021.748173. eCollection 2021.
7
Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4.慢性肾脏病背景下的心血管改变与结构变化：4型心肾综合征综述
SN Compr Clin Med. 2023;5(1):15. doi: 10.1007/s42399-022-01347-2. Epub 2022 Dec 3.
8
Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.双重内皮素-A/内皮素-B受体阻断与射血分数保留的心力衰竭中的心脏重塑
Circ Heart Fail. 2016 Nov;9(11). doi: 10.1161/CIRCHEARTFAILURE.116.003381.
9
Endothelial-Mesenchymal Transition in Heart Failure With a Preserved Ejection Fraction: Insights Into the Cardiorenal Syndrome.射血分数保留的心力衰竭中的内皮-间充质转化：对心肾综合征的见解
Circ Heart Fail. 2021 Sep;14(9):e008372. doi: 10.1161/CIRCHEARTFAILURE.121.008372. Epub 2021 Aug 19.
10
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.骨桥蛋白通过线粒体途径促进左心室舒张功能障碍。
J Am Coll Cardiol. 2019 Jun 4;73(21):2705-2718. doi: 10.1016/j.jacc.2019.02.074.

本文引用的文献

1
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology.慢性肾脏病中的心肌病：临床特征、生物标志物及小鼠模型在理解病理生理学中的作用
Clin Kidney J. 2023 Apr 18;16(11):1786-1803. doi: 10.1093/ckj/sfad085. eCollection 2023 Nov.
2
Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats.神经调节蛋白-1β改善大鼠尿毒症性心肌病和肾功能障碍。
JACC Basic Transl Sci. 2023 May 31;8(9):1160-1176. doi: 10.1016/j.jacbts.2023.03.003. eCollection 2023 Sep.
3
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.
细胞外基质在心力衰竭中的作用：ADAMTS5 在蛋白聚糖重塑中的作用。
Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22.
4
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.衰老和衰老细胞清除在心血管疾病中的应用：前景与潜在风险。
Mech Ageing Dev. 2021 Sep;198:111540. doi: 10.1016/j.mad.2021.111540. Epub 2021 Jul 6.
5
Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.尿毒症毒素在慢性肾脏病及心血管疾病进展中的作用：机制与治疗靶点。
Toxins (Basel). 2021 Feb 13;13(2):142. doi: 10.3390/toxins13020142.
6
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.心脏纤维化：细胞生物学机制、分子途径和治疗机会。
Mol Aspects Med. 2019 Feb;65:70-99. doi: 10.1016/j.mam.2018.07.001. Epub 2018 Aug 2.
7
Heart failure and kidney dysfunction: epidemiology, mechanisms and management.心力衰竭与肾脏功能障碍：流行病学、发病机制与治疗。
Nat Rev Nephrol. 2016 Oct;12(10):610-23. doi: 10.1038/nrneph.2016.113. Epub 2016 Aug 30.
8
Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability.慢性肾脏病中的心血管生物标志物：当前研究现状与临床适用性
Dis Markers. 2015;2015:586569. doi: 10.1155/2015/586569. Epub 2015 Apr 5.
9
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.衰老肾脏中血管生成受损：血管内皮生长因子和血小板反应蛋白-1与肾脏疾病
Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087.